Mrs Jaqueline Sheannette Taylor, | |
6145 Circling Hawk Dr, N Las Vegas, NV 89031-1656 | |
(702) 236-5232 | |
(702) 657-0248 |
Full Name | Mrs Jaqueline Sheannette Taylor |
---|---|
Gender | Female |
Speciality | Psychologist - Cognitive & Behavioral |
Location | 6145 Circling Hawk Dr, N Las Vegas, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669712956 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TB0200X | Psychologist - Cognitive & Behavioral | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Jaqueline Sheannette Taylor, 6145 Circling Hawk Dr, N Las Vegas, NV 89031-1656 Ph: (702) 236-5232 | Mrs Jaqueline Sheannette Taylor, 6145 Circling Hawk Dr, N Las Vegas, NV 89031-1656 Ph: (702) 236-5232 |
News Archive
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
Results reported in the April 2nd issue of the journal Cell, a Cell Press publication, reveal a new source for the drug resistance that crops up all too often and quickly in the tumors of cancer patients undergoing therapy.
Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects trends and market share in the worldwide Sleep Apnea market.
Biogen Idec announced today that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application (BLA) for ALPROLIX, the company's investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B.
Radiation exposure received from 2 to 3 computed tomography (CT) scans of the head in childhood (aged under 15 years)—giving a cumulative dose of around 60 mGy— can triple the risk of later developing brain cancer, while around 5 to 10 such scans (cumulative dose around 50 mGy) could triple the risk of developing leukaemia (with the differing number of scans related to different absorption rates of the brain versus the bone marrow and age at time of scanning).
› Verified 8 days ago
Carole Anne Jackson, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1200 Helen Ave, N Las Vegas, NV 89030 Phone: 702-275-9838 | |
Dr. Robert Moering, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3525 W Cheyenne Ave, N Las Vegas, NV 89032 Phone: 027-544-6747 | |
Dr. Kara Klingspon, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, N Las Vegas, NV 89086 Phone: 702-791-9000 | |
Denicia Powell, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3925 N Mlk Blvd Ste 212, N Las Vegas, NV 89032 Phone: 702-321-5599 | |
Glynnese Coleman, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6966 Jacksboro Ct, N Las Vegas, NV 89084 Phone: 702-689-5450 | |
H Alan Reid, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6900 Pecos Rd, Va Medical Center, N Las Vegas, NV 89086 Phone: 702-791-9000 |